These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 24157258)
1. Use of hollow fiber tangential flow filtration for the recovery and concentration of HIV virus-like particles produced in insect cells. Negrete A; Pai A; Shiloach J J Virol Methods; 2014 Jan; 195():240-6. PubMed ID: 24157258 [TBL] [Abstract][Full Text] [Related]
2. Development of EV71 virus-like particle purification processes. Lin SY; Chiu HY; Chiang BL; Hu YC Vaccine; 2015 Nov; 33(44):5966-73. PubMed ID: 25939279 [TBL] [Abstract][Full Text] [Related]
3. A Hydrodynamic Approach to the Study of HIV Virus-Like Particle (VLP) Tangential Flow Filtration. Wolf T; Rosengarten J; Härtel I; Stitz J; Barbe S Membranes (Basel); 2022 Dec; 12(12):. PubMed ID: 36557156 [TBL] [Abstract][Full Text] [Related]
4. Process intensification for high yield production of influenza H1N1 Gag virus-like particles using an inducible HEK-293 stable cell line. Venereo-Sanchez A; Simoneau M; Lanthier S; Chahal P; Bourget L; Ansorge S; Gilbert R; Henry O; Kamen A Vaccine; 2017 Jul; 35(33):4220-4228. PubMed ID: 28648546 [TBL] [Abstract][Full Text] [Related]
6. Downstream process design for Gag HIV-1 based virus-like particles. Lorenzo E; Miranda L; Gòdia F; Cervera L Biotechnol Bioeng; 2023 Sep; 120(9):2672-2684. PubMed ID: 37148527 [TBL] [Abstract][Full Text] [Related]
7. Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles. Kang CY; Luo L; Wainberg MA; Li Y Biol Chem; 1999 Mar; 380(3):353-64. PubMed ID: 10223338 [TBL] [Abstract][Full Text] [Related]
8. The effects of high shear rates on the average hydrodynamic diameter measured in biomimetic HIV Gag virus-like particle dispersions. Wolf T; Calisan KK; Stitz J; Barbe S Front Bioeng Biotechnol; 2024; 12():1367405. PubMed ID: 38860137 [TBL] [Abstract][Full Text] [Related]
9. Pilot-scale adenovirus seed production through concurrent virus release and concentration by hollow fiber filtration. Subramanian S; Altaras GM; Chen J; Hughes BS; Zhou W; Altaras NE Biotechnol Prog; 2005; 21(3):851-9. PubMed ID: 15932265 [TBL] [Abstract][Full Text] [Related]
10. Tangential flow microfiltration and ultrafiltration for human influenza A virus concentration and purification. Wickramasinghe SR; Kalbfuss B; Zimmermann A; Thom V; Reichl U Biotechnol Bioeng; 2005 Oct; 92(2):199-208. PubMed ID: 16041807 [TBL] [Abstract][Full Text] [Related]
11. Purification of HIV-1 gag virus-like particles and separation of other extracellular particles. Steppert P; Burgstaller D; Klausberger M; Berger E; Aguilar PP; Schneider TA; Kramberger P; Tover A; Nöbauer K; Razzazi-Fazeli E; Jungbauer A J Chromatogr A; 2016 Jul; 1455():93-101. PubMed ID: 27286649 [TBL] [Abstract][Full Text] [Related]
12. Constitutive expression of HIV-VLPs in stably transfected insect cell line for efficient delivery system. Tagliamonte M; Visciano ML; Tornesello ML; De Stradis A; Buonaguro FM; Buonaguro L Vaccine; 2010 Sep; 28(39):6417-24. PubMed ID: 20678589 [TBL] [Abstract][Full Text] [Related]
14. Purification of recombinant vesicular stomatitis virus-based HIV vaccine candidate. Bakhshizadeh Gashti A; Chahal PS; Gaillet B; Garnier A Vaccine; 2023 Mar; 41(13):2198-2207. PubMed ID: 36842887 [TBL] [Abstract][Full Text] [Related]
15. Virus-like particles: designing an effective AIDS vaccine. Young KR; McBurney SP; Karkhanis LU; Ross TM Methods; 2006 Sep; 40(1):98-117. PubMed ID: 16997718 [TBL] [Abstract][Full Text] [Related]
16. Chimaeric HIV-1 subtype C Gag molecules with large in-frame C-terminal polypeptide fusions form virus-like particles. Halsey RJ; Tanzer FL; Meyers A; Pillay S; Lynch A; Shephard E; Williamson AL; Rybicki EP Virus Res; 2008 May; 133(2):259-68. PubMed ID: 18329748 [TBL] [Abstract][Full Text] [Related]
17. Effect of flux and shear rate on E. coli recovery in tangential flow filtration through a single hollow fiber. Zuponcic J; Cunha F; Springer G; Ximenes E; Ladisch MR Biotechnol Prog; 2024; 40(3):e3432. PubMed ID: 38329370 [TBL] [Abstract][Full Text] [Related]
18. Virus-like particles as HIV-1 vaccines. Doan LX; Li M; Chen C; Yao Q Rev Med Virol; 2005; 15(2):75-88. PubMed ID: 15484204 [TBL] [Abstract][Full Text] [Related]
19. Expression of human immunodeficiency virus type 1 Gag protein precursor and envelope proteins from a vesicular stomatitis virus recombinant: high-level production of virus-like particles containing HIV envelope. Haglund K; Forman J; Kräusslich HG; Rose JK Virology; 2000 Mar; 268(1):112-21. PubMed ID: 10683333 [TBL] [Abstract][Full Text] [Related]
20. Polymer-grafted chromatography media for the purification of enveloped virus-like particles, exemplified with HIV-1 gag VLP. Pereira Aguilar P; Schneider TA; Wetter V; Maresch D; Ling WL; Tover A; Steppert P; Jungbauer A Vaccine; 2019 Nov; 37(47):7070-7080. PubMed ID: 31300289 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]